Correction to: Nature Communications https://doi.org/10.1038/s41467-024-49268-z, published online 26 June 2024

In this article, the Competing Interests statement was incorrectly given as ‘The authors declare no competing interests.’ And should have been ‘Girish N. Nadkarni is a founder of Renalytix, Pensieve and is a consultant to Renalytix, Heart Test Laboratories and Pensieve. He serves as a scientific advisory board member for Renalytix, Heart Test Laboratories and Pensieve. He also has equity in Renalytix, Pensieve and Verici. He has also consulted for GSK, Reata, Cambridge Capital and GLG consulting. Brian H. Kopell consults and receives consulting fees from Medtronic, Abbott, and Turing Medical. Eric Schadt has equity in, receives a salary for, and is a Corporate Executive Leader for Pathos. He is also a Board of Directors member for Sage Bionetworks and a Board of Directors member for 4YouandMe, a non-profit institute. The original article has been corrected.